Abstract
BackgroundLymphocytopenia has frequently been described in patients with malaria, but studies on its association with disease severity have yielded conflicting results. The neutrophil/lymphocyte count ratio (NLCR) has been introduced as a parameter for systemic inflammation in critically ill patients and was found, together with lymphocytopenia, to be a better predictor of bacteraemia than routine parameters like C-reactive protein and total leukocyte count. In the present study, the predictive value of the NLCR and lymphocytopenia for severe disease was evaluated in patients with imported malaria.MethodsAll patients diagnosed with malaria at the Harbour Hospital between January 1st 1999 and January 1st 2012 with differential white cell counts determined within the first 24 hours after admission were included in this retrospective study. Severe malaria was defined according to the WHO criteria. The performance of the NLCR and lymphocytopenia as a marker of severe malarial disease was compared back-to-back with that of C-reactive protein as a reference biomarker.ResultsA total of 440 patients (severe falciparum malaria n = 61, non-severe falciparum malaria n = 259, non-falciparum malaria n=120) were included in the study. Lymphocytopenia was present in 52% of all patients and the median NLCR of all patients was 3.2. Total lymphocyte counts and NLCR did not differ significantly between groups. A significant correlation of total leukocyte count and NLCR, but not lymphocyte count, with parasitaemia was found. ROC analysis revealed a good negative predictive value but a poor positive predictive value of both lymphocytopenia and NLCR and performance was inferior to that of C-reactive protein. After complete parasite clearance a significant rise in total leukocyte count and lymphocyte count and a significant decrease in NLCR was observed.ConclusionThe NLCR was found to correlate with parasitaemia, but both lymphocytopenia and the NLCR were inferior to C-reactive protein as markers for severe disease in patients with imported malaria. The NLCR and lymphocytopenia are not useful as predictive markers for severe disease in imported malaria in the acute care setting.
Highlights
Lymphocytopenia has frequently been described in patients with malaria, but studies on its association with disease severity have yielded conflicting results
The predictive value of both lymphocytopenia and the neutrophil-lymphocyte count ratio (NLCR) for bacteraemia was confirmed in a study in an emergency care setting, in which these parameters were found to be better predictors of bacteraemia than routine parameters like C-reactive protein (CRP) level, total leukocyte count or neutrophil count
The present study evaluated lymphocytopenia and the neutrophil/lymphocyte count ratio (NLCR) as predictive markers of severe disease in a large cohort of patients with imported malaria
Summary
Lymphocytopenia has frequently been described in patients with malaria, but studies on its association with disease severity have yielded conflicting results. The neutrophil/lymphocyte count ratio (NLCR) has been introduced as a parameter for systemic inflammation in critically ill patients and was found, together with lymphocytopenia, to be a better predictor of bacteraemia than routine parameters like C-reactive protein and total leukocyte count. The predictive value of the NLCR and lymphocytopenia for severe disease was evaluated in patients with imported malaria. The predictive value of both lymphocytopenia and the neutrophil-lymphocyte count ratio (NLCR) for bacteraemia was confirmed in a study in an emergency care setting, in which these parameters were found to be better predictors of bacteraemia than routine parameters like C-reactive protein (CRP) level, total leukocyte count or neutrophil count. Another study evaluated this parameter in patients with a community-acquired pneumonia (CAP) [15] and it was found to predict severity and outcome of CAP with a higher prognostic accuracy as compared with traditional infection markers
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
